
Sleep Apnea Diagnostic Devices Market by Product (Actigraphy Systems, Polysomnography (PSG) Devices, Respiratory Polygraph), Therapeutic Devices (Adaptive Servo Ventilation (ASV) Devices Masks & Accessories, Oral Appliances, Oxygen Devices), Patient Demog
Description
Sleep Apnea Diagnostic Devices Market by Product (Actigraphy Systems, Polysomnography (PSG) Devices, Respiratory Polygraph), Therapeutic Devices (Adaptive Servo Ventilation (ASV) Devices Masks & Accessories, Oral Appliances, Oxygen Devices), Patient Demographics, Distribution Channel, End-User - Global Forecast 2023-2030
The Sleep Apnea Diagnostic Devices Market size was estimated at USD 5.27 billion in 2022 and expected to reach USD 5.69 billion in 2023, at a CAGR 6.76% to reach USD 8.91 billion by 2030.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Sleep Apnea Diagnostic Devices Market.
- Based on Product, market is studied across Actigraphy Systems, Polysomnography (PSG) Devices, Respiratory Polygraph, and Sleep Apnea Screening Device. The Respiratory Polygraph is projected to witness significant market share during forecast period.
- Based on Therapeutic Devices, market is studied across Adaptive Servo Ventilation (ASV) Devices Masks & Accessories, Oral Appliances, Oxygen Devices, and Positive Airway Pressure (PAP) Devices. The Adaptive Servo Ventilation (ASV) Devices Masks & Accessories is projected to witness significant market share during forecast period.
- Based on Patient Demographics, market is studied across Adult, Geriatric, and Pediatric. The Geriatric is projected to witness significant market share during forecast period.
- Based on Distribution Channel, market is studied across Direct Tender and Retail Sales. The Retail Sales is projected to witness significant market share during forecast period.
- Based on End-User, market is studied across Ambulatory Care Centers, Diagnostic Centers, Home Healthcare, Hospital/Clinics, and Specialty Care Centers. The Home Healthcare is projected to witness significant market share during forecast period.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Sleep Apnea Diagnostic Devices Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Sleep Apnea Diagnostic Devices Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Sleep Apnea Diagnostic Devices Market, highlighting leading vendors and their innovative profiles. These include Braebon Medical Corporation, Cadwell Laboratories Inc., Compumedics Limited, DeVilbiss Healthcare, Fisher & Paykel Healthcare Corporation Limited, Invacare Corporation, Itamar Medical, Ltd., Koninklijke Philips N.V., Loewenstein Medical, Natus Medical Incorporated, Nihon Kohden Corporation, Oventus Medical, ResMed Inc., SOMNOmedics GmbH, and Vyaire Medical, Inc..
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Sleep Apnea Diagnostic Devices Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Sleep Apnea Diagnostic Devices Market?
- What is the competitive strategic window for identifying opportunities in the Sleep Apnea Diagnostic Devices Market?
- What are the latest technology trends and regulatory frameworks in the Sleep Apnea Diagnostic Devices Market?
- What is the market share of the leading vendors in the Sleep Apnea Diagnostic Devices Market?
- Which modes and strategic moves are suitable for entering the Sleep Apnea Diagnostic Devices Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
186 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Sleep Apnea Diagnostic Devices Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing cases of sleep apnea patients
- 5.1.1.2. Technological developments in devices to offer more comfort
- 5.1.1.3. Favorable reimbursement policies for sleep apnea devices and diagnostics
- 5.1.2. Restraints
- 5.1.2.1. Expensive devices need for the treatment of sleep apnea
- 5.1.3. Opportunities
- 5.1.3.1. Increase in venture capital funding
- 5.1.3.2. High potential home care segment
- 5.1.4. Challenges
- 5.1.4.1. Limited reimbursement of devices and low patient compliance
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. Sleep Apnea Diagnostic Devices Market, by Product
- 6.1. Introduction
- 6.2. Actigraphy Systems
- 6.3. Polysomnography (PSG) Devices
- 6.4. Respiratory Polygraph
- 6.5. Sleep Apnea Screening Device
- 7. Sleep Apnea Diagnostic Devices Market, by Therapeutic Devices
- 7.1. Introduction
- 7.2. Adaptive Servo Ventilation (ASV) Devices Masks & Accessories
- 7.3. Oral Appliances
- 7.4. Oxygen Devices
- 7.5. Positive Airway Pressure (PAP) Devices
- 8. Sleep Apnea Diagnostic Devices Market, by Patient Demographics
- 8.1. Introduction
- 8.2. Adult
- 8.3. Geriatric
- 8.4. Pediatric
- 9. Sleep Apnea Diagnostic Devices Market, by Distribution Channel
- 9.1. Introduction
- 9.2. Direct Tender
- 9.3. Retail Sales
- 10. Sleep Apnea Diagnostic Devices Market, by End-User
- 10.1. Introduction
- 10.2. Ambulatory Care Centers
- 10.3. Diagnostic Centers
- 10.4. Home Healthcare
- 10.5. Hospital/Clinics
- 10.6. Specialty Care Centers
- 11. Americas Sleep Apnea Diagnostic Devices Market
- 11.1. Introduction
- 11.2. Argentina
- 11.3. Brazil
- 11.4. Canada
- 11.5. Mexico
- 11.6. United States
- 12. Asia-Pacific Sleep Apnea Diagnostic Devices Market
- 12.1. Introduction
- 12.2. Australia
- 12.3. China
- 12.4. India
- 12.5. Indonesia
- 12.6. Japan
- 12.7. Malaysia
- 12.8. Philippines
- 12.9. Singapore
- 12.10. South Korea
- 12.11. Taiwan
- 12.12. Thailand
- 12.13. Vietnam
- 13. Europe, Middle East & Africa Sleep Apnea Diagnostic Devices Market
- 13.1. Introduction
- 13.2. Denmark
- 13.3. Egypt
- 13.4. Finland
- 13.5. France
- 13.6. Germany
- 13.7. Israel
- 13.8. Italy
- 13.9. Netherlands
- 13.10. Nigeria
- 13.11. Norway
- 13.12. Poland
- 13.13. Qatar
- 13.14. Russia
- 13.15. Saudi Arabia
- 13.16. South Africa
- 13.17. Spain
- 13.18. Sweden
- 13.19. Switzerland
- 13.20. Turkey
- 13.21. United Arab Emirates
- 13.22. United Kingdom
- 14. Competitive Landscape
- 14.1. FPNV Positioning Matrix
- 14.2. Market Share Analysis, By Key Player
- 14.3. Competitive Scenario Analysis, By Key Player
- 15. Competitive Portfolio
- 15.1. Key Company Profiles
- 15.1.1. Braebon Medical Corporation
- 15.1.2. Cadwell Laboratories Inc.
- 15.1.3. Compumedics Limited
- 15.1.4. DeVilbiss Healthcare
- 15.1.5. Fisher & Paykel Healthcare Corporation Limited
- 15.1.6. Invacare Corporation
- 15.1.7. Itamar Medical, Ltd.
- 15.1.8. Koninklijke Philips N.V.
- 15.1.9. Loewenstein Medical
- 15.1.10. Natus Medical Incorporated
- 15.1.11. Nihon Kohden Corporation
- 15.1.12. Oventus Medical
- 15.1.13. ResMed Inc.
- 15.1.14. SOMNOmedics GmbH
- 15.1.15. Vyaire Medical, Inc.
- 15.2. Key Product Portfolio
- 16. Appendix
- 16.1. Discussion Guide
- 16.2. License & Pricing
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.